MicroVision Receives Nasdaq Delisting Notice for Sub-$1 Bid Price
Summary
MicroVision, Inc. received a notification from Nasdaq regarding its failure to meet the minimum $1.00 bid price requirement, initiating a 180-day compliance period.
Key Events
-
Nasdaq Deficiency Notice Received
On January 12, 2026, MicroVision received a notification from Nasdaq stating it no longer meets the minimum $1.00 bid price requirement (Nasdaq Listing Rule 5450(a)(1)) for continued listing, based on the closing bid price for the last 30 consecutive business days.
-
180-Day Compliance Period
The company has 180 calendar days from the notification date to regain compliance with the Nasdaq listing rule.
-
No Immediate Delisting or Operational Impact
The notification is a deficiency notice, not an imminent delisting, and does not currently affect the trading of the company's securities. It also does not impact business operations, SEC reporting requirements, or contractual obligations.
Analysis
MicroVision's receipt of a Nasdaq deficiency notice for failing to meet the minimum $1.00 bid price requirement is a critical event. While the company has a 180-day grace period to regain compliance, the notice highlights a significant challenge to its continued listing on a major exchange. Delisting could severely impact the company's liquidity, investor confidence, and ability to attract institutional capital. Investors should closely monitor the company's strategy to address this, which may include a reverse stock split or other measures to boost the share price. The current stock price of $0.8691 underscores the immediate need for action.
At the time of this filing, MVIS was trading at $0.87 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $271.6M. The 52-week trading range was $0.81 to $1.95. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.